Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GPC planning another restructuring

GPC Biotech (FSE:GPC; GPCB) said it is planning a restructuring that will include a "significant workforce reduction." The details are still being

Read the full 224 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE